The Effectiveness of Quadro İliac Plane Block in Percutaneous Nephrolithotomies
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Quadro-İliac Plane Block(QİPB).
- Who it may be relevant to
- Registry conditions: Postoperative Pain, Percutaneous Nephrolithotomy. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Turkey (Türkiye)
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparison of the Effects of Ultrasound-Guided Quadro-İliac Plane Block on Postoperative Pain Level and Analgesia Requirement in Patients Undergoing Percutaneous Nephrolithotomy
Overview
Our aim was to investigate the effect of quadro iliac plane block on postoperative analgesia in patients undergoing percutaneous nephrolithotomy surgery and to determine which areas of the skin this block anesthetizes.
Interventions
- Procedure Quadro-İliac Plane Block(QİPB)
40 mL of 0.25% bupivacaine
Primary outcome measures
- Numeric Rating Scale (NRS) Scores [Time frame: Postoperative 24 hours]
Secondary outcome measures (2)
- Dermatome Area [Time frame: Postoperative 2 hours]
- Total tramadol consumption [Time frame: Postoperative 24 hours]
Eligibility criteria
Inclusion criteria
- Adult patients over 18 years of age who underwent percutaneous nephrolithotomy under general anesthesia and were I-II-III according to the American Society of Anesthesiologists (ASA) risk classification were included in the study.
Exclusion criteria
- patients who did not give consent,
- patients with coagulopathy,
- patients with signs of infection at the block application site,
- patients using anticoagulants,
- patients with known allergies to any of the study drugs,
- patients with unstable hemodynamics,
- patients who could not cooperate during postoperative pain assessment
- patients who wanted to withdraw from the study,
- patients with alcohol and drug addiction,
- patients with musculoskeletal abnormalities
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Quadruple blind
- Primary purpose
- Other
Study locations
Turkey (Türkiye) · 1 center
- Sivas Cumhuriyet University — Sivas
Identifiers
NCT: NCT07203859 · 2025-07/32